These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. From rhetoric to reality. Nature; 2005 Oct; 437(7061):927-8. PubMed ID: 16222253 [No Abstract] [Full Text] [Related]
6. Cautious industry welcome for US flu vaccine plan. Kling J Nat Biotechnol; 2005 Dec; 23(12):1457-8. PubMed ID: 16333275 [No Abstract] [Full Text] [Related]
7. Cell-based flu vaccines ready for US prime time. Extance A Nat Rev Drug Discov; 2011 Apr; 10(4):246. PubMed ID: 21455223 [No Abstract] [Full Text] [Related]
8. Pandemic influenza vaccine: the US government is not doing enough. Osterholm MT Clin Pharmacol Ther; 2007 Dec; 82(6):635-7. PubMed ID: 17998909 [No Abstract] [Full Text] [Related]
9. When doses disappear. Flu shot shortage sheds light on drug supply chain. Becker C Mod Healthc; 2004 Oct; 34(42):16. PubMed ID: 15552188 [No Abstract] [Full Text] [Related]
10. Commentary: From scarcity to abundance: pandemic vaccines and other agents for "have not" countries. Fedson DS; Dunnill P J Public Health Policy; 2007; 28(3):322-40. PubMed ID: 17717543 [TBL] [Abstract][Full Text] [Related]
11. National strategy for pandemic influenza released; $3.8 billion appropriated for pandemic preparedness. Mair M Biosecur Bioterror; 2006; 4(1):2-5. PubMed ID: 16602140 [No Abstract] [Full Text] [Related]
12. Financing immunization of adults in the United States. Orenstein WA; Mootrey GT; Pazol K; Hinman AR Clin Pharmacol Ther; 2007 Dec; 82(6):764-8. PubMed ID: 17971821 [TBL] [Abstract][Full Text] [Related]
13. Protecting the nation's health: ensuring a stable supply of influenza vaccine. Seiguer E Issue Brief (Commonw Fund); 2005 Jul; (832):1-14. PubMed ID: 16193600 [TBL] [Abstract][Full Text] [Related]
14. The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901-1902. Lilienfeld DE Perspect Biol Med; 2008; 51(2):188-98. PubMed ID: 18453724 [TBL] [Abstract][Full Text] [Related]
15. Vaccine availability in the US: problems and solutions. Poland GA; Marcuse EK Nat Immunol; 2004 Dec; 5(12):1195-8. PubMed ID: 15549115 [No Abstract] [Full Text] [Related]
16. The winning shot. New vaccine technologies to offer pinpoint attacks on a variety of potentially deadly diseases. Kirchheimer B Mod Healthc; 2005 Nov; 35(46):52-4. PubMed ID: 16334833 [No Abstract] [Full Text] [Related]
17. Aches and pains. Learning lessons from the influenza vaccine shortage. Fink S IAVI Rep; 2004 Dec-2005 Mar; 9(1):10-1. PubMed ID: 16110570 [No Abstract] [Full Text] [Related]
18. Strengthening the supply of routinely recommended vaccines in the United States: a perspective from the American Medical Association. Tan L; Clin Infect Dis; 2006 Mar; 42 Suppl 3():S121-4. PubMed ID: 16447133 [TBL] [Abstract][Full Text] [Related]
19. Influenza vaccine prebooking and distribution strategies for the 2005-2006 influenza season. Ann Pharmacother; 2005 Jun; 39(6):1151. PubMed ID: 15886288 [No Abstract] [Full Text] [Related]
20. US lacks back-up for flu vaccine shortfall. Pearson H Nature; 2004 Oct; 431(7010):726. PubMed ID: 15483568 [No Abstract] [Full Text] [Related] [Next] [New Search]